MeSH tree: D23.101.140.625
Omitting biopsy in patients with negative magnetic resonance imaging (MRI) results is associated with a significantly reduced relative risk for detecting clinically insignificant prostate cancer, according to a study published ...
Sep 27, 2024
0
34
The prostate is a small gland in males that aids in reproduction. Prostate cancer is one of the most common types of cancer, and when it's detected early, often by a simple blood test, it has the best chance for successful ...
Sep 19, 2024
0
40
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
Sep 16, 2024
0
41
A new survey finds the majority of American men believe the first step in prostate cancer screening is an invasive rectal exam by their doctor.
Sep 9, 2024
0
29
In a recent comprehensive review published in Cyborg Bionic Systems, researchers detail significant advances in the identification and application of biomarkers for prostate cancer (PCa). This critical insight is pivotal ...
Aug 23, 2024
0
42
Two reduced dose radiopharmaceutical therapy approaches for advanced stage metastatic castrate-resistant prostate cancer have been shown to be just as effective as the standard dose, according to new research published in ...
Jul 24, 2024
0
65
The Stockholm3 blood test, developed by researchers at Karolinska Institutet, is equally effective at detecting prostate cancer in different ethnic groups, a new paper published in the Journal of Clinical Oncology reports. ...
Jul 22, 2024
0
39
Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in JAMA concludes that current screening guidelines could miss early-stage prostate cancer in transgender ...
Jun 26, 2024
0
26
Treating prostate cancer with immunotherapy is currently difficult to do. But results from a first in-human Phase I trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope, ...
Jun 12, 2024
0
47
Extended prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy (177Lu-PSMA) beyond six cycles is an effective and well-tolerated treatment for metastatic castration-resistant prostate cancer patients, ...
Jun 4, 2024
0
48
